We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

EMEA (Europe, Middle East and Africa) Anti-Aging Products and Therapies Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In this report, the EMEA Anti-Aging Products and Therapies market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Anti-Aging Products and Therapies for these regions, from 2014 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Aging Products and Therapies market competition by top manufacturers/players, with Anti-Aging Products and Therapies sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Allergan
Ipsen
Lanzhou Institute
Corneal(Allergan)
Galdermal
LG Life Science
Bohus BioTech
IMEIK
Merck
Gaoxin

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Human Growth Hormone
Stem Cell
Placenta
Botulinum Toxin
Hyaluronic Acid

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Anti-Aging Products and Therapies for each application, including
Hospital
Beauty Parlor

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Anti-Aging Products and Therapies Market Report 2019
1 Anti-Aging Products and Therapies Overview
1.1 Product Overview and Scope of Anti-Aging Products and Therapies
1.2 Classification of Anti-Aging Products and Therapies
1.2.1 EMEA Anti-Aging Products and Therapies Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA Anti-Aging Products and Therapies Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Human Growth Hormone
1.2.4 Stem Cell
1.2.5 Placenta
1.2.6 Botulinum Toxin
1.2.7 Hyaluronic Acid
1.3 EMEA Anti-Aging Products and Therapies Market by Application/End Users
1.3.1 EMEA Anti-Aging Products and Therapies Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Hospital
1.3.3 Beauty Parlor
1.4 EMEA Anti-Aging Products and Therapies Market by Region
1.4.1 EMEA Anti-Aging Products and Therapies Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of Anti-Aging Products and Therapies (2014-2024)
1.5.1 EMEA Anti-Aging Products and Therapies Sales and Growth Rate (2014-2024)
1.5.2 EMEA Anti-Aging Products and Therapies Revenue and Growth Rate (2014-2024)

2 EMEA Anti-Aging Products and Therapies Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Anti-Aging Products and Therapies Market Competition by Players/Manufacturers
2.1.1 EMEA Anti-Aging Products and Therapies Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Anti-Aging Products and Therapies Revenue and Share by Players (2014-2019)
2.1.3 EMEA Anti-Aging Products and Therapies Sale Price by Players (2014-2019)
2.2 EMEA Anti-Aging Products and Therapies (Volume and Value) by Type/Product Category
2.2.1 EMEA Anti-Aging Products and Therapies Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Anti-Aging Products and Therapies Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Anti-Aging Products and Therapies Sale Price by Type (2014-2019)
2.3 EMEA Anti-Aging Products and Therapies (Volume) by Application
2.4 EMEA Anti-Aging Products and Therapies (Volume and Value) by Region
2.4.1 EMEA Anti-Aging Products and Therapies Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Anti-Aging Products and Therapies Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Anti-Aging Products and Therapies Sales Price by Region (2014-2019)

3 Europe Anti-Aging Products and Therapies (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Anti-Aging Products and Therapies Sales and Value (2014-2019)
3.1.1 Europe Anti-Aging Products and Therapies Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Anti-Aging Products and Therapies Revenue and Growth Rate (2014-2019)
3.2 Europe Anti-Aging Products and Therapies Sales and Market Share by Type
3.3 Europe Anti-Aging Products and Therapies Sales and Market Share by Application
3.4 Europe Anti-Aging Products and Therapies Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Anti-Aging Products and Therapies Sales Volume by Countries (2014-2019)
3.4.2 Europe Anti-Aging Products and Therapies Revenue by Countries (2014-2019)
3.4.3 Germany Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
3.4.4 France Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
3.4.5 UK Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
3.4.6 Russia Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
3.4.7 Italy Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
3.4.8 Benelux Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)

4 Middle East Anti-Aging Products and Therapies (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Anti-Aging Products and Therapies Sales and Value (2014-2019)
4.1.1 Middle East Anti-Aging Products and Therapies Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Anti-Aging Products and Therapies Revenue and Growth Rate (2014-2019)
4.2 Middle East Anti-Aging Products and Therapies Sales and Market Share by Type
4.3 Middle East Anti-Aging Products and Therapies Sales and Market Share by Application
4.4 Middle East Anti-Aging Products and Therapies Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Anti-Aging Products and Therapies Sales Volume by Countries (2014-2019)
4.4.2 Middle East Anti-Aging Products and Therapies Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
4.4.4 Israel Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
4.4.5 UAE Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
4.4.6 Iran Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)

5 Africa Anti-Aging Products and Therapies (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Anti-Aging Products and Therapies Sales and Value (2014-2019)
5.1.1 Africa Anti-Aging Products and Therapies Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Anti-Aging Products and Therapies Revenue and Growth Rate (2014-2019)
5.2 Africa Anti-Aging Products and Therapies Sales and Market Share by Type
5.3 Africa Anti-Aging Products and Therapies Sales and Market Share by Application
5.4 Africa Anti-Aging Products and Therapies Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Anti-Aging Products and Therapies Sales Volume by Countries (2014-2019)
5.4.2 Africa Anti-Aging Products and Therapies Revenue by Countries (2014-2019)
5.4.3 South Africa Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
5.4.5 Egypt Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)
5.4.6 Algeria Anti-Aging Products and Therapies Sales and Growth Rate (2014-2019)

6 EMEA Anti-Aging Products and Therapies Manufacturers/Players Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Ipsen
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Ipsen Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Lanzhou Institute
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Lanzhou Institute Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Corneal(Allergan)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Corneal(Allergan) Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Galdermal
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Galdermal Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 LG Life Science
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 LG Life Science Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Bohus BioTech
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bohus BioTech Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 IMEIK
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 IMEIK Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Gaoxin
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Anti-Aging Products and Therapies Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Gaoxin Anti-Aging Products and Therapies Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview

7 Anti-Aging Products and Therapies Manufacturing Cost Analysis
7.1 Anti-Aging Products and Therapies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Aging Products and Therapies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Aging Products and Therapies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Aging Products and Therapies Major Manufacturers in 2018
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Anti-Aging Products and Therapies Market Forecast (2019-2024)
11.1 EMEA Anti-Aging Products and Therapies Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA Anti-Aging Products and Therapies Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA Anti-Aging Products and Therapies Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA Anti-Aging Products and Therapies Price and Trend Forecast (2019-2024)
11.2 EMEA Anti-Aging Products and Therapies Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe Anti-Aging Products and Therapies Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt Anti-Aging Products and Therapies Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa Anti-Aging Products and Therapies Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA Anti-Aging Products and Therapies Sales Forecast by Type (2019-2024)
11.7 EMEA Anti-Aging Products and Therapies Sales Forecast by Application (2019-2024)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.